A novel anti-regurgitation (AR) formula combining carob bean gum (CBG) with prebiotics and postbiotics was found to have a more pronounced benefit for infants with more severe gastrointestinal (GI) symptoms, according to the results of a post hoc analysis presented at WCPGHAN 2021.
The inclusion of a clinical oncology pharmacist into an ambulatory care pharmacy in paediatric haematology–oncology and transplant clinic results in reduced adverse events and fewer readmission into the hospital, a study has shown.
Treatment with the fully human anti-IL17 monoclonal antibody secukinumab resulted in fewer, and a longer time to, disease flares in children and adolescents with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA), results of the phase III JUNIPERA trial showed.
Treatment with COVID-19 convalescent plasma (CCP) leads to a rapid increase in antibodies and is well tolerated in paediatric patients but does not seem to interfere with immune responses measured at 21 days, results of a recent study have shown.
Prehospital antibiotic therapy (PH-ABT) leads to a marked decrease in the overall rate of bacterial pathogen detection by culture, but not by polymerase chain reaction, in children with parapneumonic pleural effusion (PPE) and pleural empyema (PE), a study has found. PH-ABT also results in a reduced rate of infectious complications but does not have an impact on the overall disease duration.
Consuming caffeinated beverages* during pregnancy – even at levels below the ACOG**-recommended daily dose of 200 mg – may lead to small reductions in neonatal anthropometric measurements, according to a secondary analysis of the NICHD*** Foetal Growth Studies-Singletons.